Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350648 · ClinicalTrials.gov registry record
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
A clinical trial of Hepatitis C and Hepatitis B, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 569
- Enrollment target
- 2
- Study locations
NCT01350648 is a study of Hepatitis C and Hepatitis B that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 569 participants, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01350648, a study of Hepatitis C and Hepatitis B, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 569 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: \- Hepatitis B and hepatitis C can cause liver damage. They can also cause serious illness, including liver cancer, and even death. This study will follow people who have hepatitis B or hepatitis C. The purpose is to understand more about how these viruses affect the immune system over the long term (up to 10 years). The study will also compare how these viruses affect people who do and do not have HIV, the virus that causes AIDS. Objectives: * To do a long-term study of hepatitis B and hepatitis C infection. * To study the effects of hepatitis B and hepatitis C infection in people do and do not have HIV. Eligibility: \- People at least 18 years of age who have hepatitis B or hepatitis C and have a regular doctor for their medical care. Design: * Participants will be screened with a physical exam and medical history. Those who do not have a regular doctor to provide medical care during the study will not be able to take part. * Participants will have yearly visits with study researchers for up to 10 years. These tests will be done at each visit. * Medical history and physical exam. * Questionnaire (optional) on emotions, sexual behaviors, use of alcohol and drugs, and quality of life. * Blood and urine tests, including HIV testing. * Tissue sample collections for those who have had a liver or other tissue biopsy. * Participants may leave the study at any time. They will receive the standard of care from their regular doctor throughout the study.
Conditions Studied
Study Locations (2)
District of Columbia
- VA Medical Center, Washington D.C. - Washington D.C.
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2011-08-23 |
| Est. Completion | 2022-03-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01350648
The ClinicalTrials.gov registry entry for NCT01350648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 569 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (70% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01350648 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Maryland.
Frequently Asked Questions
What is clinical trial NCT01350648 about?
NCT01350648 is a clinical study titled "Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection". Background: \- Hepatitis B and hepatitis C can cause liver damage. They can also cause serious illness, including liver cancer, and even death. This study will follow people who have hepatitis B or hepatitis C. The purpose is to understand more about how these viruses affect the immune system over ...
What is the current status of trial NCT01350648?
This trial is currently completed. The enrollment target is 569 participants. The study started on 2011-08-23. Estimated completion is 2022-03-17.
What conditions does trial NCT01350648 study?
This clinical trial studies the following conditions: Hepatitis C, Hepatitis B, HIV-HCV Co-Infection.
Who is sponsoring clinical trial NCT01350648?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01350648 being conducted?
This trial has 2 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.